MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Inclusion Criteria:African AmericanReceiving hemodialysis treatmentsBeen on hemodialysis for more than 30 days18 years of age and olderWithin a 2-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes.Exclusion Criteria:Not self-identified as African AmericanImpaired with mental status or severe illnessNon-English speakingNo documented evidence of dialysis treatment non-adherenceMissed or shortened treatments due to hospitalizations or excused travelTerminal conditionLiving in a nursing home/rehabPlanned transplant within the next 6 monthsPlanned conversion to peritoneal dialysis within the next 6 months